Home FAQs Support WebAudit Audit Codes Download Files View Instructions Standards of Care Past Results Get Epi Info
  The Unofficial
IHS Diabetes Care & Outcomes Audit
Support Site		  
 

Hosted by Ray Shields, MD

               Preface     

Welcome to AUDIT 2010!

 
If you have not previously participated in an IHS Diabetes Chart Audit, please take time to read these instructions carefully before beginning your audit activities.
 

 

Even if you are already familiar with the annual Diabetes Audit process, you will find that there are changes for 2010.  Refer to the information below for a brief summary of this year's changes. Use the Quick Start directions for a concise review of the steps involved in performing either a manual or an electronic audit.  

The WebAudit, fully implemented during the 2008 audit cycle, will continue to  supplant the previously used Epi Info audit program, providing a more secure method of transmitting the audit data to the IHS Division of Diabetes and an easier way of producing reports.

What's new in AUDIT 2010?

 

l    New items

     -   No new elements, but some new choices under established elements (see below under “Modification of items/reports”).

    

l    Deleted items  

  -   The fields for Area, Service Unit, and Facility codes have been deleted from the audit form because they are now automatically provided by the WebAudit.

  -   The number of patients in the diabetes register (REGNUM) and the questions related to SDPI grants have been deleted from the audit form because they do not apply to individual records; this information is requested in a separate section of the WebAudit.

l    Modification of  items/reports

   -   The “DM Therapy” section contains a new choice:

  •  Sulfonylurea-like (Prandin, Starlix)  

                        (in previous audits these medications were included within the Sulfonylurea choice, but they are now separated out into their own group).

 

 

-    The Lipid Lowering Agent section has been expanded to include Yes/No choices for seven groups of lipid lowering medications:

               Statin (simvastatin/Zocor, others)

               Fibrate (gemfibrozil/Lopid, others)

               Niacin (Niaspan, OTC niacin)

               Bile Acid Sequestrant (cholestyramine/Questran, others)

               Ezetimibe (Zetia)

               Fish Oil (Rx or OTC)

               Lovaza

 

       

-    The TB testing section contains a new choice:

              Blood test (QFT-G, T SPOT-TB

               Most sites will continue to use PPD but where appropriate, sites may opt to use and document the CDC-approved QFT-G or T SPOT-TB if they wish.

   

 -   The section on urine protein testing has been revised:

The reviewer now is asked whether the patient had urine protein testing during the audit period.  If the answer is Yes, the reviewer is then asked to specify the type of urine protein testing performed and the result.  Choices are:

                 

(1)   Urine Albumin:Creatinine Ratio (UACR) --->  Provide value in mg/g.

(2)    Urine Protein:Creatinine Ratio (UPCR)  ---->  Provide value in g/g.

(3)   24 hour urine protein ----> Provide value in mg/24 hrs  

(4)   Microalbumin:creatinine strip (e.g., Clinitek) ----> Provide range:

                                  (1) <30 mg/g

                                  (2) 30-300 mg/g

                                  (3) >300 mg/g

(5)   Microalbumin strip (e.g., Micral) ----> Provide range:

                                  (1) <20 mg/L

                                  (2) >20 mg/L

(6)   UA dipstick  ----> Select result:

                                  (1) Normal or trace

                                  (2) Abnormal (>1+)

 

     -  Several audit elements have been re-ordered on the audit form and standard audit report, so that they now appear in a different location on the form or report than they did in previous audits.  The re-ordering was necessary due to physical space considerations.

 
Back